(R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole,
(R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide,
3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide,
eletriptan,
eletriptan hydrobromide,
Relpax,
UK 166,044,
UK 166044,
UK-116,044-04,
UK-116044-04,
UK-166,044,
UK-166044,
Eletriptan,
143322-58-1,
Relpax,
Eletriptan [INN:BAN],
UK 116044,
UNII-22QOO9B8KI,
UK-116044-04,
CHEBI:50922,
UK-116044,
22QOO9B8KI,
(R)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole,
UK-116044-04 [As Hydrobromide),
NCGC00181130-01,
3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole,
3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole,
5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole,
5-[2-(benzenesulfonyl)ethyl]-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole,
DSSTox_CID_26861,
DSSTox_RID_81968,
DSSTox_GSID_46861,
eletriptanum,
177834-92-3,
Eletriptan Free Base,
1H-Indole, 3-(((2R)-1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)ethyl)-,
Eletriptan (INN),
CAS-143322-58-1,
UK-116,044,
GTPL40,
CHEMBL1510,
SCHEMBL26719,
AC1L2U98,
DTXSID9046861,
CTK8F9426,
KS-00000XLD,
PWVXXGRKLHYWKM-LJQANCHMSA-N,
ZINC3823475,
Tox21_112737,
BDBM50103594,
AKOS005145842,
AKOS015851019,
Tox21_112737_1,
AC-3397,
ACN-046382,
AM84392,
AN-5266,
DB00216,
SB19514,
UK-116,044-04 [as hydrobromide],
NCGC00181130-02,
NCGC00181130-04,
AJ-45734,
BC220499,
CC-27448,
AB1004885,
LS-186998,
LS-187637,
FT-0667836,
D07887,
834E923,
C-21362,
J-510369,
(R)-5-(2-Phenylsulfonylethyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole,
3-(N-methyl-2(R)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl)-1H-indole,
(R)-5-(2-benzenesulphonylethyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole,
3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-5-(2-phenylsulfonylethyl)-1H-indole,
3-{[1-methylpyrrolidin-2(R)-yl]methyl}-5-(2-phenylsulphonylethyl)-1H-indole,
(R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-Indole; (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole; Eletriptan,
Eletriptan HBr,
Eletriptan hydrobromide,
Relpax (TN),
D02DMQ,
2-Fluoro-3-iodobenzoic acid,
CID77993,
C22-H26-N2-O2-S,
UK116044,
UK 166044,
UK-166044,
2568B,
UK 166,044,
UK-166,044,
UK 116044-04,
UK-116,044-04,
C115647,
(R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole,
(R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole,
(R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-Indole,
(S)-3-((1-Methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole,
1h-indol, 3-[[(2r)-1-metil-2-pirrolidinil]metil]-5-[2-(fenilsulfonil)etil]-,
1H-Indole 3-[(1-methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-(R)-,
1H-Indole, 3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-,
3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide,
3-[[(2r)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1h-indole,
5-[2-(benzenesulfonyl)ethyl]-3-(1-methylpyrrolidin-2(R)-ylmethyl)-1H-indole,
(R)-3-((1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide,